Covid-19 vaccine: Govt examining Pfizer’s request for indemnity, will take decision on merit, says VK Paul

At a press conference, Paul said, "Yes we are engaged with Pfizer and they have indicated the availability of a certain amount of vaccine in the coming months, possibly starting in July."

Pfizer Covid-19 vaccine

Eicher Motors, Sun Pharma, Cadila, TCS, BPCL, Burger King, Pfizer, PNB Housing stocks in focus

Nifty futures were trading flat at 15,305 in early trade on Singaporean Exchange, suggesting a cautious opening for BSE Sensex and Nifty 50 on Thursday.

Eicher Motors, Sun Pharma, Cadila, TCS, BPCL, Burger King, Pfizer, PNB Housing, stocks in focus

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt

Another source privy to the discussions said that following recent meetings between the Indian government and Pfizer's Chairman and CEO Albert Bourla, they have agreed to jointly work on three key issues to accelerate approva

Pfizer Covid-19 vaccine

Covid-19: Pfizer seeks speedy nod for Pfizer-BioNTech vaccine supply in India

“Pfizer is aware that access to vaccines is critical to ending this pandemic. Unfortunately, our vaccine is not registered in India,” Bourla said.

Pfizer had in April offered a 'not-for-profit' price for its vaccine for the Indian government's immunisation programme.

Govt must free up Covid-19 vaccine pricing

It must heed Pfizer’s call; price caps, export controls will discourage pvt sector participation in India’s vaccination efforts

While regulatory ease could be debated from either end, pricing and export freedom is a must.

WHO gives ‘emergency validation’ to Pfizer-BioNTech corona vaccine, calls for equitable global access

The WHO, together with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global effort called COVAX to distribute vaccines to low- and middle-income countries.

world health organisation emergency use authorisation to pfizer vaccine

Pfizer share price zooms over 19% to new 52-week high on COVID-19 vaccine news; rallies 63% since March

Pfizer also indicated that the company is on track later this month to file an emergency use application with US regulators.

Pfizer vaccine, Pfizer covid-19 vaccine, pfizer share price

Pfizer signs definitive merger agreement with Anacor Pharmaceuticals

To acquire Anacor Pharmaceuticals for $5.2 billion Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total tra

Piramal Enterprises acquires four brands from Pfizer for Rs 110 crore

The agreement also includes the trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka Piramal Enterprises’ Consumer Products Division has entered into an agreement to acquire four brands from

Pfizer says it’s blocking use of drugs for lethal injections

Pharmaceutical company Pfizer said Friday it was blocking use of its drugs in lethal injections, which means all federally-approved drugmakers whose medications could be used for executions have now put them off limits.


Pfizer Q4 net profit spikes 57 pc to Rs 67 cr

Drug firm Pfizer on Friday reported a 56.9 per cent rise in its standalone net profit at Rs 66.9 crore for the March quarter.

Pfizer Q4 results

Delhi HC questions govt over urgency to ban over 300 FDC drugs

Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla

Pfizer calls off $160-billion merger with Allergan

The decision to call off the merger came after the US Treasury Department announced new rules to discourage mergers between US and foreign businesses designed to sharply lower the US company’s tax bill US pharmaceutical

Is pharma companies still a good bet post drugs ban?

Shares of pharmaceutical companies hogged the limelight this week after the Ministry of Health & Family Welfare banned sale of over 300 fixed-dose combinations (FDC) in India with immediate effect.


Delhi High Court interim stay of notification stopping sale of Corex syrup

Justice Rajiv Sahai Endlaw granted the interim relief to the company saying it has been selling the cough syrup for the last 25 years

Court stays ban on Pfizer’s Corex cough syrup

In a relief to pharma major Pfizer and giving hopes for several others, the Delhi High Court on Monday stayed a government notification that banned manufacture...

Pfizer Q4 results

Health Ministry bans 344 fixed dose combination drugs

Health Ministry has banned about 344 fixed dose combination drugs, including cough syrups compositions, saying they involve "risk" to humans and safer alternatives were available.


Pfizer stops sale of Corex after government ban

Pfizer said Corex maintains a ‘well established efficacy and safety profile in India’ and the ‘company is exploring all available options at its disposal’ Pfizer has discontinued manufacture and sale o

Pfizer shares tanks over 8% after it stops selling Corex cough syrup

Pfizer share price skid over 7 per cent intraday on Monday after the company informed stock exchanges that it has discontinued the manufacture and sale of its drug “Corex” with immediate effect.


Pfizer launches Gelusil liquid in sachet format

The product has been rolled out simultaneously in metros, smaller towns and rural areas Pfizer’s GEP (Global Established Products) division in India has kaunched Gelusil liquid in a ready-to-drink, on-the-go sachet format.

EMA accepts Sandoz application for biosim etanercept

The EMA's acceptance follows recent US FDA regulatory submission acceptance

Pfizer, IIT Delhi launch ‘Innovation & IP Program’

The programme will help to create healthcare innovations in India Pfizer with IIT Delhi have announced the launch of ‘The Pfizer IIT-Delhi Innovation and IP Program’, an incubation accelerator initiative co-created by Pfi

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market

Most Read


Top News


Related Articles